PLOS Medicine: Scaling Up mHealth: Where Is the Evidence?
14/02/2013Why digital healthcare means strategy is now vital – PMLiVE
14/02/2013The 20 biggest growing pharma products in 2012 – Sanofi’s Lantus leads the way
Sanofi’s diabetes treatment Lantus was the industry’s biggest annual revenue growth driver in 2012, with sales expanding by $1.4 billion versus 2011 levels. Two other products contributed annual growth in excess of $1 billion; AbbVie’s Humira (+$1.3 billion) and Merck & Co.’s Januvia/Janumet (+$1.1 billion).
See on www.firstwordpharma.com
